Formulations for the administration of fluoxetine
US6512010B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Jul 14, 1997 |
| Grant date | Jan 28, 2003 |
| Priority date | — |
| Expiry date | Jul 14, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/57
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Composition of matter for application to a body surface or membrane to administer fluoxetine by permeation through the body surface or membrane, the composition comprising fluoxetine to be administered, at a therapeutically effective rate, alone or in combination with a permeation enhancer or mixture. A preferred embodiment is directed to the transdermal administration of fluoxetine at reduced skin irritation levels wherein fluoxetine, preferably provided as fluoxetine acetate, is coadministered with a corticosteroid such as hydrocortisone. Also disclosed are drug delivery devices containing the fluoxetine or fluoxetine and enhancer composition and methods for the transdermal administration of the fluoxetine and fluoxetine/enhancer composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.